王有志｜山东大学｜学者主页

2026

Correction: The Comprehensive Complication Index for Assessing Short-Term Complications of Urothelial Carcinoma with Variant Histology: A Patient-Based Study

Youzhi Wang, Ning Wu, Fan Zhang, Shu-Dong Zhang

Annals of Surgical Oncology

2026

Using human proteomic and lipidomic to exploration drug target of bladder cancer

Qian Cao, Hong-Yan Liu, Yangyang Xu, Youzhi Wang, Liupan An, Jun-Bo Li, Hai-Tao Ren, Diansheng Zhou, Jiaming Liang, Zhaokai Guan, Wei-Wei Wang, Chang-Li Wu, Yang Yang, Jianmei Wang, Ning Jiang

World journal of urology

DOI

2026

The Quartet of Core Oncogenic Drivers in Neuroendocrine Prostate Cancer: Multi-Omics Dataset Integration to Forge a Translational Link Between Biology and Precision Therapy

Youzhi Wang, Ning Wu, Jun-Bo Li, Qian Cao, Jian-Fei Ye, Shu-Dong Zhang

International Journal on Biological Sciences

DOI

2026

Engineering Therapeutic Super-Competitor Cells for Educative Cancer Treatment and Ecological Replacement.

Youzhi Wang, Ning Wu, Yihao Liao, Jun-Bo Li, Chang-Chang Li, Jiaming Liang, Diansheng Zhou, L. Ge, Xiaobo Chen, Shu-Dong Zhang

Cancer Letters

DOI

2026

Ferroptosis-autophagy crosstalk in bladder cancer: mechanisms and therapeutic implications

Youzhi Wang, Ning Wu, Shu-Dong Zhang

Molecular Cancer

DOI

2025

LINC00525 drives aggressive phenotypes in bladder cancer via YAP stabilization-mediated transcriptional activation

Jiaming Liang, Shu-Yue Guo, Youzhi Wang, Qian Cao, Tao Guo, Diansheng Zhou, Jun-Bo Li, Yihao Liao, Boqiang Zhong, Ning Jiang

Cancer Cell International

DOI

2024

The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer.

Youzhi Wang, Ning Wu, Jun-Bo Li, Jiaming Liang, Diansheng Zhou, Qian Cao, Xue-Song Li, Ning Jiang

Pharmacological Research

DOI

2024

Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway

Yihao Liao, Jiaming Liang, Youzhi Wang, An Li, Wen-Bo Liu, Boqiang Zhong, Keke Wang, Diansheng Zhou, Tao Guo, Jianing Guo, Xi Yu, Ning Jiang

International Journal on Biological Sciences

DOI

2024

YAP1 Regulates the YAP1/AR/PSA Axis through Autophagy in Castration-Resistant Prostate Cancer and Mediates T-Cell Immune and Inflammatory Cytokine Infiltration

Youzhi Wang, Ning Wu, Jun-Bo Li, Diansheng Zhou, Jiaming Liang, Qian Cao, Zhaokai Guan, Yangyang Xu, Ning Jiang

Biomedicines

DOI

2023

MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma

Boqiang Zhong, Youzhi Wang, Yihao Liao, Jia-Ming Liang, Keke Wang, Diansheng Zhou, Yang Zhao, Ning Jiang

Apoptosis

DOI

2023

TNIK drives castration-resistant prostate cancer via phosphorylating EGFR

Jianing Guo, Jiaming Liang, Youzhi Wang, Tao Guo, Yihao Liao, Boqiang Zhong, Shu-Yue Guo, Qian Cao, Jun-Bo Li, A. Flores-Morales, Y. Niu, Ning Jiang

iScience

DOI

2023

Ferroptosis landscape in prostate cancer from molecular and metabolic perspective

Jia-Ming Liang, Yihao Liao, Pu Wang, Kun-Han Yang, Youzhi Wang, Keke Wang, Boqiang Zhong, Diansheng Zhou, Qian Cao, Jun-Bo Li, Yang Zhao, Ning Jiang

Cell Death Discovery

DOI

2022

Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer

Ning Wu, Youzhi Wang, Keke Wang, Boqiang Zhong, Yihao Liao, Jia-Ming Liang, Ning Jiang

Cell Death and Disease

DOI

2022

Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study

Youzhi Wang, Ning Wu, Keke Wang, Yihao Liao, Jianing Guo, Boqiang Zhong, Tao Guo, Jia-Ming Liang, Ning Jiang

Frontiers in Genetics

DOI

2021

The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta‐analysis

Yihao Liao, Huiqing Tang, Miaomiao Wang, Keke Wang, Youzhi Wang, Ning Jiang

Journal of clinical laboratory analysis (Print)

DOI

2021

Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

Youzhi Wang, Ning Wu, Ning Jiang

Cell Death and Disease

DOI

2021

Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?

Yihao Liao, Meng-Yue Yang, Keke Wang, Youzhi Wang, Boqiang Zhong, Ning Jiang

Cancer Letters

DOI

2021

Correction: Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

Youzhi Wang, N. Wu, Ning Jiang

Cell Death and Disease

DOI

2021

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway

Ning Jiang, Yihao Liao, Miaomiao Wang, Youzhi Wang, Keke Wang, Jianing Guo, Peikang Wu, Boqiang Zhong, Tao Guo, Chang-Li Wu

Journal of experimental & clinical cancer research : CR

DOI

2021

Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer

Yihao Liao, Xuan-Xuan Zou, Keke Wang, Youzhi Wang, Miaomiao Wang, Tao Guo, Boqiang Zhong, Ning Jiang

Journal of Cancer

DOI

2020

TNIK swaths AR to WNT pathway and drives Castration-Resistant Prostate Cancer

Ning Jiang, Tao Guo, Miaomiao Wang, Yihao Liao, Fuling Ma, Jie Gao, Youzhi Wang, Keke Wang, Yu-Dong Wu, Amílcar Flores Morales, Y. Niu

DOI

2020

OTUB1 Promotes Progression and Proliferation of Prostate Cancer via Deubiquitinating and Stabling Cyclin E1

Yihao Liao, N. Wu, Keke Wang, Miaomiao Wang, Youzhi Wang, Jie Gao, Bo-Qiang Zhong, Fuling Ma, Yu-Dong Wu, Ning Jiang

Frontiers in Cell and Developmental Biology

DOI

2017

新常态下产业技术升级政策研究——以江苏省为例

王有志，张巍巍，张玉赋

《科技进步与对策》，Vol. 34, No. 10

下载原文

2015

基于创新诊断的企业科技创新发展对策研究

王有志，庄雨婷，姚缘，李丰男

《科技进步与对策》，Vol. 32, No. 9

下载原文

2014

我国医药制造业研发投入产出效率与对策——基于医药制造业PanalDate的实证研究

孙峰，王有志，余景亮

《科技进步与对策》，Vol. 31, No. 22

下载原文

王有志

精选作品

期刊论文

Correction: The Comprehensive Complication Index for Assessing Short-Term Complications of Urothelial Carcinoma with Variant Histology: A Patient-Based Study

Using human proteomic and lipidomic to exploration drug target of bladder cancer

The Quartet of Core Oncogenic Drivers in Neuroendocrine Prostate Cancer: Multi-Omics Dataset Integration to Forge a Translational Link Between Biology and Precision Therapy

Engineering Therapeutic Super-Competitor Cells for Educative Cancer Treatment and Ecological Replacement.

Ferroptosis-autophagy crosstalk in bladder cancer: mechanisms and therapeutic implications

LINC00525 drives aggressive phenotypes in bladder cancer via YAP stabilization-mediated transcriptional activation

The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine prostate cancer.

Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway

YAP1 Regulates the YAP1/AR/PSA Axis through Autophagy in Castration-Resistant Prostate Cancer and Mediates T-Cell Immune and Inflammatory Cytokine Infiltration

MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma

TNIK drives castration-resistant prostate cancer via phosphorylating EGFR

Ferroptosis landscape in prostate cancer from molecular and metabolic perspective

Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer

Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study

The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta‐analysis

Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?

Correction: Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway

Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer

TNIK swaths AR to WNT pathway and drives Castration-Resistant Prostate Cancer

OTUB1 Promotes Progression and Proliferation of Prostate Cancer via Deubiquitinating and Stabling Cyclin E1

新常态下产业技术升级政策研究——以江苏省为例

基于创新诊断的企业科技创新发展对策研究

我国医药制造业研发投入产出效率与对策——基于医药制造业PanalDate的实证研究